Veterinary Medicines

KOLIBIN RC NEO, injekcinė emulsija galvijams

Authorised
  • Bovine rotavirus A, type G6P1, strain TM-91, Inactivated
  • Bovine coronavirus, strain C-197, Inactivated
  • Escherichia coli, serotype O8:K35 (fimbrial adhesin F5), Inactivated
  • Escherichia coli, serotype O9:K35 (fimbrial adhesin F5), Inactivated
  • Escherichia coli, serotype O101:K30 (fimbrial adhesin F5), Inactivated
Download as PDF

Product identification

Medicine name:
KOLIBIN RC NEO, injekcinė emulsija galvijams
Active substance:
  • Bovine rotavirus A, type G6P1, strain TM-91, Inactivated
  • Bovine coronavirus, strain C-197, Inactivated
  • Escherichia coli, serotype O8:K35 (fimbrial adhesin F5), Inactivated
  • Escherichia coli, serotype O9:K35 (fimbrial adhesin F5), Inactivated
  • Escherichia coli, serotype O101:K30 (fimbrial adhesin F5), Inactivated
Target species:
  • Cattle (heifer)
  • Cattle (pregnant cow)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Bovine rotavirus A, type G6P1, strain TM-91, Inactivated
    1.00
    relative potency
    /
    2.00
    millilitre(s)
  • Bovine coronavirus, strain C-197, Inactivated
    1.00
    relative potency
    /
    2.00
    millilitre(s)
  • Escherichia coli, serotype O8:K35 (fimbrial adhesin F5), Inactivated
    1.00
    relative potency
    /
    2.00
    millilitre(s)
  • Escherichia coli, serotype O9:K35 (fimbrial adhesin F5), Inactivated
    1.00
    relative potency
    /
    2.00
    millilitre(s)
  • Escherichia coli, serotype O101:K30 (fimbrial adhesin F5), Inactivated
    1.00
    relative potency
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetmarket UAB
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/21/2692/001-004
Date of authorisation status change:

Documents

RV2692.pdf

Lithuanian (PDF)
Published on: 14/06/2022
Download